Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000346809

Medchemexpress LLC Romaciclib monohydrochloride | 2443816-41-7 | 99.3% | 450.60 | 25 MG
SDP

Catalog No. 5000346809
Encompass_Preferred

Romaciclib monohydrochloride is an ATP-competitive and selective CDK8 inhibitor. It inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50s of 4.4 nM and 10.4 nM, respectively, and has a Kd of 3 nM for CDK8. It weakly inhibits CDK9 but shows no significant activity against CDK1, 2, 4, 6, 5, or 7. This compound inhibits phosphorylation of STAT1 S727 and STAT5 S726, demonstrating anti-tumor activity.

  • ATP-competitive and selective CDK8 inhibitor.
  • Inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes.
  • Weakly inhibits CDK9 and shows no obvious activity against several other CDKs (CDK1, 2, 4, 6, 5, 7).
  • Inhibits phosphorylation of STAT1 S727 and STAT5 S726.
  • Possesses anti-tumor activity.
  • Decreases IRF9 and STAT1 mRNA expression and mitogen-induced IER expression.
  • Inhibits growth of AML tumors in a dose-dependent manner in SCID mice.

Catalog No. 50-003-46809 Supplier Medchemexpress LLC Supplier No. 25MGHY111388A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Romaciclib monohydrochloride is an ATP-competitive and selective CDK8 inhibitor. It inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50s of 4.4 nM and 10.4 nM, respectively, and has a Kd of 3 nM for CDK8. It weakly inhibits CDK9 but shows no significant activity against CDK1, 2, 4, 6, 5, or 7. This compound inhibits phosphorylation of STAT1 S727 and STAT5 S726, demonstrating anti-tumor activity.

  • ATP-competitive and selective CDK8 inhibitor.
  • Inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes.
  • Weakly inhibits CDK9 and shows no obvious activity against several other CDKs (CDK1, 2, 4, 6, 5, 7).
  • Inhibits phosphorylation of STAT1 S727 and STAT5 S726.
  • Possesses anti-tumor activity.
  • Decreases IRF9 and STAT1 mRNA expression and mitogen-induced IER expression.
  • Inhibits growth of AML tumors in a dose-dependent manner in SCID mice.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.